Literature DB >> 20397954

Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned.

Andrea A Howard1, Wafaa M El-Sadr.   

Abstract

Promoting linkages between tuberculosis (TB) and human immunodeficiency virus (HIV) treatment and prevention programs in resource-constrained environments where both diseases are prevalent is essential to improve the diagnosis, treatment, and outcomes for patients affected by both diseases. In this article, we share insights based on our experiences supporting integrated TB and HIV service delivery programs, including intensified TB case finding, isoniazid preventive therapy, infection control, and initiation of antiretroviral therapy. Our experience indicates that successful integration of TB and HIV services in resource-constrained environments is feasible, although programmatic, infrastructural, and staffing challenges remain. Successful implementation of TB and HIV collaborative activities requires consideration of the realities that exist on the ground and the importance of tailoring interventions in a manner that enables their seamless introduction into existing programs that are often overwhelmed with large numbers of patients and a paucity of human and other resources.

Entities:  

Mesh:

Year:  2010        PMID: 20397954     DOI: 10.1086/651497

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  47 in total

1.  Antiretroviral treatment among co-infected tuberculosis patients in integrated and non-integrated facilities.

Authors:  T D Ledibane; S C Motlhanke; A Rose; W H Kruger; N R T Ledibane; M M Claassens
Journal:  Public Health Action       Date:  2015-06-21

2.  One-stop TB-HIV services evaluation in Rwanda: comparison of the 2001-2005 and 2006-2010 cohorts.

Authors:  A Ndagijimana; E Rugigana; C B Uwizeye; J Ntaganira
Journal:  Public Health Action       Date:  2015-12-21

3.  Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana.

Authors:  A B Schwartz; N Tamuhla; A P Steenhoff; K Nkakana; R Letlhogile; T R Chadborn; M Kestler; N M Zetola; S Ravimohan; G P Bisson
Journal:  Int J Tuberc Lung Dis       Date:  2013-10       Impact factor: 2.373

4.  Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.

Authors:  Diane V Havlir; Michelle A Kendall; Prudence Ive; Johnstone Kumwenda; Susan Swindells; Sarojini S Qasba; Anne F Luetkemeyer; Evelyn Hogg; James F Rooney; Xingye Wu; Mina C Hosseinipour; Umesh Lalloo; Valdilea G Veloso; Fatuma F Some; N Kumarasamy; Nesri Padayatchi; Breno R Santos; Stewart Reid; James Hakim; Lerato Mohapi; Peter Mugyenyi; Jorge Sanchez; Javier R Lama; Jean W Pape; Alejandro Sanchez; Aida Asmelash; Evans Moko; Fred Sawe; Janet Andersen; Ian Sanne
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

5.  Dotting the Three I's for collaborative TB-HIV activities: evaluation of a pilot programme in Kathmandu, Nepal.

Authors:  S K Sah; S K Sahu; B Lamichhane; G K Bhatta; K B Bhandari; P Owiti; S S Majumdar
Journal:  Public Health Action       Date:  2016-09-21

6.  TB/HIV integration at primary care level: A quantitative assessment at 3 clinics in Johannesburg, South Africa.

Authors:  L Page-Shipp; Y Voss De Lima; K Clouse; J de Vos; L Evarts; J Bassett; I Sanne; A Van Rie
Journal:  South Afr J HIV Med       Date:  2012-09       Impact factor: 2.744

7.  Screening tuberculosis patients for diabetes in a tribal area in South India.

Authors:  S Achanta; R R Tekumalla; J Jaju; C Purad; R Chepuri; R Samyukta; S Malhotra; S B Nagaraja; A M V Kumar; A D Harries
Journal:  Public Health Action       Date:  2013-11-04

8.  A home tracing program for contacts of people with tuberculosis or HIV and patients lost to care.

Authors:  C B Deery; C F Hanrahan; K Selibas; J Bassett; I Sanne; A Van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

Review 9.  A systematic review of published literature describing factors associated with tuberculosis recurrence in people living with HIV in Africa.

Authors:  Yoshan Moodley; Kumeren Govender
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

10.  Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines.

Authors:  Kimcheng Choun; Reaksmey Pe; Sopheak Thai; Natalie Lorent; Lutgarde Lynen; Johan van Griensven
Journal:  Bull World Health Organ       Date:  2012-12-12       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.